U.S. Juice Disruption Erases Growth Across Four Acomo Segments
A production bottleneck in Acomo’s U.S. juice business outweighed revenue growth across every other reported operating segment in the third quarter. That is the clearest reading of the Rotterdam-listed ingredient group’s 22 October trading update, and it makes the company’s plan to bring more juice processing in-house a material operating test for early 2027.
Group sales were €352.5 million in the quarter, down 1% from €357.3 million a year earlier and down 2% at constant currencies. The headline decline looks mild. Underneath it, however, Organic Ingredients lost €18.6 million of quarterly sales while Spices & Nuts, Edible Seeds, Tea and Food Solutions added a combined €14.1 million.
Agrilinkage calculates that the four growing segments offset about 76% of the Organic Ingredients decline. Put differently, the loss in that one division was roughly 32% larger than the gains elsewhere. The figures point to a concentrated operational problem rather than a group-wide collapse in customer demand.
One division erased four sources of growth
Organic Ingredients generated €129.5 million of Q3 sales, 13% below the €148.1 million recorded a year earlier. At about 36.7% of group sales, it remained large enough for a localized disruption to determine the consolidated result.
Acomo segment | Q3 2026 sales | Year-on-year | Euro change |
Spices & Nuts | €133.2m | +5% | +€6.9m |
Edible Seeds | €50.3m | +2% | +€1.1m |
Organic Ingredients | €129.5m | -13% | -€18.6m |
Tea | €30.5m | +5% | +€1.6m |
Food Solutions | €10.8m | +70% | +€4.5m |
The table uses Acomo’s reported segment figures. Euro changes are Agrilinkage calculations from the current and prior-year quarterly sales disclosed by the company. The segment totals include a negative €1.7 million contribution from holding activities and intra-group eliminations, so they do not add to group sales without that adjustment.
The group result also shows why percentage growth needs scale. Food Solutions rose 70%, the fastest rate in the portfolio, but its €10.8 million of sales represented only about 3.1% of the quarterly total. Its €4.5 million gain was meaningful, yet it could offset less than one-quarter of the Organic Ingredients shortfall.
The U.S. juice problem and the insourcing response
Acomo attributed the Organic Ingredients weakness primarily to production problems at a third-party facility serving its U.S. juice operation. The company did not disclose the lost volume, the affected product mix, or the supplier’s identity. It did say that demand in the wider segment remained stable and that other Organic Ingredients businesses performed solidly.
That distinction matters. A demand-driven decline could require price action, product changes or a lower capacity base. A third-party production failure instead raises questions about redundancy, qualification of alternative processors, inventory buffers and control over a critical step in the supply chain.
Management expects a new in-house U.S. juice-processing operation to become operational in the first quarter of 2027. If it starts on schedule and reaches stable output, the investment could reduce dependence on the external production arrangement that constrained sales. It could also improve control over scheduling, quality and customer service. Those benefits remain prospective: the update did not provide capital expenditure, designed capacity, commissioning milestones or expected margin effects.
The four growing segments were not all growing for the same reason
Spices & Nuts reached €133.2 million of sales, up 5%. Acomo cited growth across multiple markets, supportive price conditions and the contribution of Manuzzi, the Italian nuts and snack company acquired in November 2025. Because the update did not separate acquisition revenue from like-for-like growth, the reported increase should not be read as a pure measure of underlying volume.
Edible Seeds rose 2% to €50.3 million. Acomo said the segment benefited from recovering production at SunButter, its U.S. sunflower-seed spread business, while European market activity remained subdued. At constant currencies, segment sales were approximately flat. The difference between reported and constant-currency growth suggests that foreign-exchange translation helped the euro figure.
Tea sales increased 5% to €30.5 million despite what the company described as geopolitical uncertainty. The division is also moving toward a centralized commercial model, an organizational change whose effect on customer retention, inventory deployment and margins will become clearer only in later reporting.
Food Solutions increased sales to €10.8 million, helped by the July 2026 acquisition of Cublend, a Dutch specialist in dry food-ingredient blending. As with Manuzzi, Acomo did not quantify the acquired contribution. The quarter therefore confirms portfolio expansion, but it does not yet show how much of the segment’s 70% rise came from organic demand.
Acomo also reported that cocoa performed well amid volatile prices. Cocoa sits within the broader portfolio rather than appearing as a separately reported segment in the quarterly table, limiting the ability to distinguish price effects from physical volume and mix.
The nine-month and balance-sheet context
For the first nine months, group sales were €1.063 billion, 5% below the €1.116 billion recorded in the same period of 2025 and 3% lower at constant currencies. Organic Ingredients was again the largest drag, down 15% to €383.2 million. Spices & Nuts rose 4% to €409.4 million, Tea gained 4% to €86.7 million and Food Solutions increased 23% to €23.6 million. Edible Seeds fell 5% to €164.8 million.
The sales update contained no third-quarter profit or cash-flow figures, so it cannot establish whether the group’s margins improved or deteriorated. Acomo’s first-half results provide the latest fuller financial frame: adjusted gross margin edged up to 16.4% from 16.2%, but adjusted EBIT fell 11% to €52.1 million and adjusted net profit dropped 18% to €33.5 million. Leverage was 2.9 times adjusted EBITDA, up from 2.1 times a year earlier.
For scale, Acomo reported €1.464 billion of full-year sales in 2025. The Q3 figures imply that repairing the U.S. juice operation matters more to the group’s near-term revenue trajectory than the eye-catching growth rate of its smallest segment.
What to watch next
The first test is timing: whether the in-house U.S. juice facility becomes operational during Q1 2027 as planned. The second is ramp quality: beginning production is not the same as reaching reliable commercial throughput. Investors and customers will need evidence on yields, service levels and whether outsourced constraints have actually been removed.
The third test is earnings quality. Future reporting should show whether Organic Ingredients revenue recovers without sacrificing margin, and whether the Manuzzi and Cublend acquisitions contribute profitable growth after integration costs. Segment-level volume, price and acquisition bridges would make that assessment substantially easier.
For food manufacturers, the broader lesson is that diversified ingredient portfolios still carry single-process risk. A group can sell nuts, seeds, tea, cocoa and blended food solutions across many markets, yet one constrained processing step can erase growth elsewhere when it sits inside a large division.
Methodology and disclosure
This analysis uses Acomo’s 22 October 2026 trading update, its first-half 2026 results and its full-year 2025 results. Agrilinkage calculated euro changes, segment shares and offsets from the figures in those documents. The company’s quarterly update reports revenue, not third-quarter profitability or physical volumes, and acquisitions, currency, price and product mix may affect comparisons. The illustration is original editorial artwork and is not a photograph of an Acomo site.
Comments